tiprankstipranks
Trending News
More News >
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Income Statement

Compare
295 Followers

Revelation Biosciences Income Statement

Last quarter (Q4 2025), Revelation Biosciences's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Revelation Biosciences's net income was $-2.51M. See Revelation Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -27.06K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 9.04M$ 7.98M$ 8.66M$ 10.86M$ 11.95M
Depreciation and Amortization
$ 27.06M$ 27.92K$ 25.05K$ 25.05K$ 16.78K
EBITDA
$ 18.14M$ -7.95M$ -8.63M$ -10.84M$ -11.93M
Operating Income
$ -9.07M$ -7.98M$ -8.66M$ -10.86M$ -11.95M
Other Income/Expenses
$ 157.16K$ -7.06M$ 8.54M$ 34.96K$ -36.35K
Pretax Income
$ -8.91M$ -15.04M$ -120.25K$ -10.83M$ -11.99M
Net Income
$ -8.91M$ -15.04M$ -120.25K$ -10.83M$ -11.99M
Per Share Metrics
Basic EPS
$ -23.95$ -87.68$ -8.41$ -9.64K$ -20.40K
Diluted EPS
$ -23.95$ -87.68$ -8.41$ -9.64K$ -20.40K
Weighted Average Shares Outstanding
6.21M 171.51K 14.29K 1.12K-
Weighted Average Shares Outstanding (Diluted)
6.21M 171.51K 14.29K 1.12K-
Currency in USD

Revelation Biosciences Earnings and Revenue History